American Journal of Kidney Diseases
Volume 53, Issue 2 , Pages 290-297 , February 2009

Associations of Dialysis Modality and Infectious Mortality in Incident Dialysis Patients in Australia and New Zealand

  • David W. Johnson, PhD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    • Corresponding Author InformationAddress correspondence to David W. Johnson, PhD, Department of Nephrology, Level 2, ARTS Bldg, Princess Alexandra Hospital, Ipswich Rd, Woolloongabba, Brisbane Qld 4102, Australia
    • ,
  • Hannah Dent, BSc(Hons)

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Discipline of Public Health, University of Adelaide, Adelaide, Australia
    • ,
  • Carmel M. Hawley, MMedSci

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    • ,
  • Stephen P. McDonald, PhD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Department of Nephrology and Transplantation Services, University of Adelaide at the Queen Elizabeth Hospital, Adelaide, Australia
    • ,
  • Johan B. Rosman, MD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Renal Department, Middlemore Hospital, Otahuhu, Auckland, New Zealand
    • ,
  • Fiona G. Brown, PhD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Department of Nephrology, Monash Medical Center, Clayton, Victoria, Australia
    • ,
  • Kym M. Bannister, MD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Department of Nephrology, Royal Adelaide Hospital, Adelaide, Australia
    • ,
  • Kathryn J. Wiggins, MD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • University of Melbourne Department of Nephrology, St Vincent's Hospital, Fitzroy, Victoria, Australia

Received 25 February 2008 ,Accepted 7 July 2008.

References 

  1. US Renal Data System. USRDS 2006 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  2. Johnson DW, McDonald SP, Excell L, Livingston B, Shtangey V. Peritoneal dialysis. In:  McDonald SP,  Excell L editor. ANZDATA Registry Report 2005. Adelaide, South Australia: ANZDATA; 2006;p. 84–100
  3. Johnson DW, Chang S, Excell L, Livingston B, Bannister K, McDonald SP. Peritoneal dialysis. In:  McDonald SP,  Excell L editor. ANZDATA Registry Report 2006. Adelaide, South Australia: ANZDATA; 2007;p. 87–103
  4. Foley RN, Guo H, Snyder JJ, Gilbertson DT, Collins AJ. Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol. 2004;15:1038–1045
  5. Abbott KC, Agodoa LY. Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States. Nephron. 2002;91:203–209
  6. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int. 1999;55:1081–1090
  7. Aslam N, Bernardini J, Fried L, Burr R, Piraino B. Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol. 2006;1:1226–1233
  8. McDonald SP, Chang S, Excell L. ANZDATA Registry Report 2007. Adelaide, Australia: Australian and New Zealand Dialysis and Transplant Registry; 2007;
  9. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51:524–532
  10. Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev. 2004;CD004679
  11. Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials. Am J Kidney Dis. 2004;44:591–603
  12. Digenis GE, Abraham G, Savin E, et al. Peritonitis-related deaths in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int. 1990;10:45–47
  13. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl. 2006;103:S55–S62
  14. Blake PG. Peritoneal dialysis in Asia: An external perspective. Perit Dial Int. 2002;22:258–264
  15. Abbott KC, Agodoa LY. Etiology of bacterial septicemia in chronic dialysis patients in the United States. Clin Nephrol. 2001;56:124–131
  16. Aslam N, Bernardini J, Fried L, Piraino B. Large body mass index does not predict short-term survival in peritoneal dialysis patients. Perit Dial Int. 2002;22:191–196
  17. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: A propensity score analysis. J Am Soc Nephrol. 2004;15:477–486
  18. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 Study. Kidney Int. 2005;68:311–318
  19. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control. 2004;32:155–160
  20. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol. 2002;23:716–720
  21. Colville LA, Lee AH. Retrospective analysis of catheter-related infections in a hemodialysis unit. Infect Control Hosp Epidemiol. 2006;27:969–973
  22. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Epidemiology of vascular access in the Australian hemodialysis population. Kidney Int. 2003;64:1893–1902
  23. Polkinghorne KR, McDonald SP, Marshall MR, Atkins RC, Kerr PG. Vascular access practice patterns in the New Zealand hemodialysis population. Am J Kidney Dis. 2004;43:696–704
  24. Di Benedetto A, Basci A, Cesare S, Marcelli D, Ponce P, Richards N. Increased use of catheters as vascular access: Is it justified by patients' clinical conditions?. J Vasc Access. 2007;8:21–27
  25. Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL. Haemodialysis vascular access problems in Canada: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant. 2006;21:721–728
  26. Li SQ, Cass A, Cunningham J. Cause of death in patients with end-stage renal disease: Assessing concordance of death certificates with registry reports. Aust N Z J Public Health. 2003;27:419–424
  27. Goodkin DA, Bragg-Gresham JL, Koenig KG, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14:3270–3277

 Originally published online as doi:10.1053/j.ajkd.2008.06.032 on September 22, 2008.

PII: S0272-6386(08)01194-3

doi: 10.1053/j.ajkd.2008.06.032

American Journal of Kidney Diseases
Volume 53, Issue 2 , Pages 290-297 , February 2009

Article Tools

* Image Usage & Resolution